European Union - English - EMA (European Medicines Agency)

ge healthcare as - mangafodipir trisodium - magnetic resonance imaging - contrast media - this medicinal product is for diagnostic use only.contrast medium for diagnostic magnetic resonance imaging (mri) for the detection of lesions of the liver suspected to be due to metastatic disease or hepatocellular carcinomas. as an adjunct to mri to aid in the investigation of focal pancreatic lesions.

Canada - English - Health Canada

ge healthcare canada inc - mangafodipir trisodium - solution - 37.9mg - mangafodipir trisodium 37.9mg - miscellaneous therapeutic agents

New Zealand - English - Medsafe (Medicines Safety Authority)

ge healthcare limited t/a ge healthcare - medical diagnostics - mangafodipir trisodium 0.01 mmol/ml - solution for infusion - 0.01 mmol/ml - active: mangafodipir trisodium 0.01 mmol/ml excipient: ascorbic acid sodium chloride water for injection

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

amersham health - mangafodipir trisodium - solution for infusion - .01mmol/1ml

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

amersham health a.s., norway - mangafodipir trisodium - solution - 7.57 mg/ml